 |
 |
 |
||
|
||||
 |
|
| Updated Sep. 9, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
| |
|
Study: Substantial Number of Opioid Patients Not Taking Drugs as Prescribed
ISSUE: AUGUST, 2009 Irregularities seen in three-fourths of urine drug testing (UDT) samples of patients prescribed opioids for chronic pain indicate that patients were most likely not taking their medications as directed, leading study researchers to stress the importance of UDT in this population. read more | |
|
Acetaminophen Drops Recalled
ISSUE: JULY, 2009 Brookstone Pharmaceuticals and the FDA have notified health care professionals and consumers of a nationwide voluntary recall of all lots of Concentrated Acetaminophen Drops (NDC#42192-504-16) in 16 ounce (473 ml) bulk containers. read more | |
|
Remifentanil Linked to Adverse Events in Patients Dependent On Opioids
ISSUE: JUNE, 2009 Remifentanil, a short-acting opioid commonly used for surgical anesthesia, may cause severe opioid-induced hyperalgesia and acute opioid tolerance in patients who are dependent on opiates. read more | |
|
ER Gabapentin Effective for Postherpetic Neuralgia in Phase III Trials
ISSUE: JUNE, 2009 Extended-release gabapentin provides relief for postherpetic neuralgia, a Phase III study suggests. Although results did not reach significance at the study’s primary end point—pain relief after 10 weeks in comparison with placebo—encouraging data for pain relief, sleep quality and side-effect profiles suggest that further trials should explore once-daily dosing, according to one of the trial investigators. read more | |
|
Anti-Nausea Drug May Help Treat Opioid Addiction
ISSUE: MAY, 2009 Seattle—The drug ondansetron, approved by the FDA to treat nausea and vomiting, appears to overcome many of the problems associated with current treatments for opioid addiction with little likelihood of serious side effects. read more | |
|
Opioids May Suppress Adrenal Hormones
ISSUE: MAY, 2009 Long-term opioid therapy may cause suppression of adrenal corticosteroids in some patients, a new study shows. read more | |
|
APS Opioid Guidelines Nearing Publication
ISSUE: NOVEMBER, 2008 After a summer of peer review and minor modifications, the American Pain Society’s guidelines for opioid management of chronic noncancer pain have been submitted for publication. read more | |
|
IT Naloxone and Haloperidol Boost Opioid Analgesia
ISSUE: NOVEMBER, 2008 For patients in severe pain, adding a second agent to morphine may augment the opioid’s analgesic effects, two new case studies suggest. Enhanced analgesia would be particularly useful in patients with intractable or postoperative pain, experts said. read more |
| |
| MOREPHARMACOLOGY | |
| |
|
• |
New CR-Oxycodone Holds its own in Ethanol, Avoids ... [11/2008] |
|
• |
Decade of Painkillers... [10/2008] |
|
• |
Consensus Guidelines Find Methadone Underused in P... [10/2008] |
|
• |
Study Sees Surge in NSAID-related Liver Damage... [8/2008] |
|
• |
Bone Drugs Urged for Pain Relief—Some Experts Puzz... [5/2008] |
|
• |
Neurolysis Has Place for Pain... [3/2008] |
|
• |
Pain Therapy in Five Easy Pieces... [12/2007] |
|
• |
Anticonvulsant Reduces Pain and Impact of Fibromya... [8/2007] |
|
• |
Cannabinoid Reduces Pain, Anxiety in Patients With... [8/2007] |
|
• |
Analgesic Effect of Duloxetine Occurs Before Its E... [8/2007] |
|
• |
Letter to the Editor... [8/2007] |
|
• |
COX-2 Inhibitor Shows Safety, Efficacy Following A... [8/2007] |
|
• |
Botulinum Toxin Block Shows Efficacy for Chronic H... [6/2007] |
|
• |
Extended-Relief Agent Shows Efficacy in Opioid-Nai... [6/2007] |
|
• |
MNTX Eases Opioid-Induced Constipation... [6/2007] |
 Pharmacology Archives | |
| home | about us | advertise | contact | publications |